T. Ebihara

Species differences of organic anion transporters involved in the renal uptake of 4‐amino‐3‐chlorophenyl hydrogen sulfate, a metabolite of resatorvid, between rats and dogs

S. Asahi, T. Itoh, Y. Tagawa, 2013, Biopharmaceutics & drug disposition.

Pharmacokinetics of TAK-475, a Squalene Synthase Inhibitor, in Rats and Dogs

S. Asahi, T. Moriwaki, Y. Tagawa, 2016, Drug Research.

Marked impact of P‐glycoprotein on the absorption of TAK‐427 in rats

S. Asahi, T. Higuchi, Y. Maeshiba, 2008, Biopharmaceutics & drug disposition.

Fasiglifam (TAK-875) Alters Bile Acid Homeostasis in Rats and Dogs: A Potential Cause of Drug Induced Liver Injury

Andy Z. X. Zhu, Y. Dragan, M. Vakilynejad, 2017, Toxicological sciences : an official journal of the Society of Toxicology.

The effect of elevated α1-acid glycoprotein on the pharmacokinetics of TAK-272 (SCO-272), an orally active renin inhibitor, in rats

T. Higuchi, Y. Tagawa, Masami Yamamoto, 2018, Xenobiotica; the fate of foreign compounds in biological systems.

Establishment and Characterization of the Transformants Stably-Expressing MDR1 Derived from Various Animal Species in LLC-PK1

T. Yokoi, S. Asahi, T. Higuchi, 2006, Pharmaceutical Research.

Characterization of Transporters in the Hepatic Uptake of TAK-475 M-I, a Squalene Synthase Inhibitor, in Rats and Humans

S. Asahi, T. Moriwaki, Y. Tagawa, 2016, Drug Research.

Absorption of TAK-491, a new angiotensin II receptor antagonist, in animals

S. Asahi, Y. Tagawa, T. Takeuchi, 2013, Xenobiotica; the fate of foreign compounds in biological systems.

Differences in nonclinical pharmacokinetics between species and prediction of human pharmacokinetics of TAK‐272 (SCO‐272), a novel orally active renin inhibitor

Y. Tagawa, M. Nishihara, F. Jinno, 2018, Biopharmaceutics & drug disposition.

Characterization of Fasiglifam-Related Liver Toxicity in Dogs

L. Benet, Liping Pan, I. Mori, 2019, Drug Metabolism and Disposition.